1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. District of Columbia >
  6. Neuren Pharmaceuticals Acquires Hamilton Pharmaceuticals

M&A Deal Summary

Neuren Pharmaceuticals Acquires Hamilton Pharmaceuticals

On October 16, 2007, Neuren Pharmaceuticals acquired medical products company Hamilton Pharmaceuticals

Acquisition Highlights
  • This is Neuren Pharmaceuticals’ 1st transaction in the Medical Products sector.
  • This is Neuren Pharmaceuticals’ 1st transaction in the United States.
  • This is Neuren Pharmaceuticals’ 1st transaction in District of Columbia.

M&A Deal Summary
Date 2007-10-16
Target Hamilton Pharmaceuticals
Sector Medical Products
Buyer(s) Neuren Pharmaceuticals
Deal Type Add-on Acquisition

Target

Hamilton Pharmaceuticals

Washington, District of Columbia, United States
Hamilton Pharmaceuticals, Inc. develops medical treatments for central nervous system disease.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Neuren Pharmaceuticals

Camberwell, Australia
Category Company
Founded 2001
Sector Medical Products
Employees8
Revenue 213M AUD (2024)
DESCRIPTION

Neuren Pharmaceuticals is a biopharmaceutical company developing new therapies for brain injury, neurodevelopmental, and neurodegenerative disorders. Neuren Pharmaceuticals was founded in 2001 and is based in Camberwell, Australia.

DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: District of Columbia M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2007 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal